Articles

Pharma and biotech patent litigation

April 15, 2014

In the April–June 2014 edition of Corporate Disputes, Group Vice President and Global Practice Leader Dr. Gregory Bell and other industry experts discuss pharma and biotech patent litigation.

Download

Related Capabilities

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com

Intellectual Property
CRA Insights

IP Insights: Notable developments in IP litigation: April 2021

Sprint Communications Company LP v. WideOpenWest, Inc. et al., Case No. 1-18-cv-00361 (US District Court of Delaware) Sprint Communications filed lawsuits...
Intellectual Property
Articles

Trademarks as risk-based investments

Systematic risks are often unavoidable and can quickly erode value. The current pandemic has impacted the entire economy, especially the retail and consumer...

Explore our thinking

Intellectual Property
Sponsorship

June 21-22, 2021

Virtual Conference

The 2021 Sedona Conference on Developing Guidelines for Trade Secret Issues

CRA is a proud sponsor of this event. For more information on this event, click here.

See all events

Pharma and biotech patent litigation

Meet the authors

Related Insights

IP Insights: Notable developments in IP litigation: April 2021

Trademarks as risk-based investments

Upcoming Events

The 2021 Sedona Conference on Developing Guidelines for Trade Secret Issues